Works matching DE "VEDOLIZUMAB"

Results: 423
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission.

    Published in:
    Journal of Gastrointestinal & Liver Diseases, 2023, v. 32, n. 4, p. 452, doi. 10.15403/jgld-5084
    By:
    • Parisio, Laura;
    • Settanni, Carlo Romano;
    • Varca, Simone;
    • Laterza, Lucrezia;
    • Lopetuso, Loris Riccardo;
    • Napolitano, Daniele;
    • Schiavoni, Elisa;
    • Turchini, Laura;
    • Fanali, Caterina;
    • Alfieri, Norma;
    • Pizzoferrato, Marco;
    • Papa, Alfredo;
    • Pafundi, Pia Clara;
    • Armuzzi, Alessandro;
    • Gasbarrini, Antonio;
    • Pugliese, Daniela;
    • Scaldaferri, Franco
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19

    Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis.

    Published in:
    Digestive Diseases & Sciences, 2024, v. 69, n. 5, p. 1808, doi. 10.1007/s10620-023-08252-1
    By:
    • Peyrin-Biroulet, L.;
    • Bossuyt, P.;
    • Bettenworth, D.;
    • Loftus Jr., E. V.;
    • Anjie, S. I.;
    • D'Haens, G.;
    • Saruta, M.;
    • Arkkila, P.;
    • Park, H.;
    • Choi, D.;
    • Kim, D- H.;
    • Reinisch, W.
    Publication type:
    Article
    20
    21
    22
    23
    24

    Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.

    Published in:
    Digestive Diseases & Sciences, 2022, v. 67, n. 3, p. 1007, doi. 10.1007/s10620-021-06907-5
    By:
    • Bamias, Giorgos;
    • Kokkotis, Georgios;
    • Gizis, Michalis;
    • Kapizioni, Christina;
    • Karmiris, Konstantinos;
    • Koureta, Evgenia;
    • Kyriakos, Nikolaos;
    • Leonidakis, Georgios;
    • Makris, Konstantinos;
    • Markopoulos, Panagiotis;
    • Michalopoulos, Georgios;
    • Michopoulos, Spyridon;
    • Papaconstantinou, Ioannis;
    • Polymeros, Dimitrios;
    • Siakavellas, Spyros I.;
    • Triantafyllou, Konstantinos;
    • Tsironi, Eftychia;
    • Tsoukali, Emmanouela;
    • Tzouvala, Maria;
    • Viazis, Nikos
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational study.

    Published in:
    Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 1, p. 69, doi. 10.17219/acem/162969
    By:
    • Zagórowicz, Edyta;
    • Cichoż-Lach, Halina;
    • Kopertowska-Majchrzak, Maria;
    • Eder, Piotr;
    • Stawczyk-Eder, Kamila;
    • Talar-Wojnarowska, Renata;
    • Zatorski, Hubert;
    • Solarska-Półchłopek, Anna;
    • Filip, Rafał;
    • Janiak, Maria;
    • Skrobot, Krzysztof;
    • Kłopocka, Maria;
    • Liebert, Ariel;
    • Kaczka, Aleksandra;
    • Wojciechowski, Krzysztof;
    • Drygała, Szymon;
    • Michalak, Agata
    Publication type:
    Article
    41
    42
    43
    44
    45

    Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study.

    Published in:
    2021
    By:
    • Garcia-Romero, Ruth;
    • de Zabarte Fernandez, José Miguel Martinez;
    • Pujol-Muncunill, Gemma;
    • Donat-Aliaga, Ester;
    • Segarra-Cantón, Oscar;
    • Irastorza-Terradillos, Iñaki;
    • Medina-Benitez, Enrique;
    • Ruiz-Hernández, Carlos José;
    • Carrillo-Palau, Marta;
    • Ros-Arnal, Ignacio;
    • Rodriguez-Martínez, Alejandro;
    • Escartin-Madurga, Laura;
    • Gutiérrez-Junquera, Carolina;
    • Vicente-Santamaría, Saioa;
    • Rodriguez-Belvis, Marta Velasco;
    • Fernández-Fernández, Sonia;
    • Alberto-Alonso, José Ramón;
    • Montraveta, Montserrat;
    • Torres-Peral, Ricardo;
    • Navalon-Rubio, María
    Publication type:
    Correction Notice
    46

    Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study.

    Published in:
    European Journal of Pediatrics, 2021, v. 180, n. 9, p. 3029, doi. 10.1007/s00431-021-04063-6
    By:
    • Garcia-Romero, Ruth;
    • Martinez de Zabarte Fernandez, José Miguel;
    • Pujol-Muncunill, Gemma;
    • Donat-Aliaga, Ester;
    • Segarra-Cantón, Oscar;
    • Irastorza-Terradillos, Iñaki;
    • Medina-Benitez, Enrique;
    • Ruiz-Hernández, Carlos José;
    • Carrillo-Palau, Marta;
    • Ros-Arnal, Ignacio;
    • Rodriguez-Martínez, Alejandro;
    • Escartin-Madurga, Laura;
    • Gutiérrez-Junquera, Carolina;
    • Vicente-Santamaría, Saioa;
    • Velasco Rodriguez-Belvis, Marta;
    • Fernández-Fernández, Sonia;
    • Alberto-Alonso, José Ramón;
    • Montraveta, Montserrat;
    • Torres-Peral, Ricardo;
    • Navalon-Rubio, María
    Publication type:
    Article
    47
    48
    49
    50